SIGN UP FOR UPDATES!
Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
ENGLEMED
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BOOKS AND GIFTS THIS WAY!
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
SEARCH THIS SITE
Google

WWW Englemed
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
FreeDigitalPhotos
www.freedigitalphotos.net
FreeWebPhotos
www.freewebphoto.com
FROM OUR NEWS FEEDS
Antivirals may help monkeypox patients
Wed May 25th - Antiviral medications may be effective against monkeypox, researchers have found, but more research is urgently needed. More
Anti-ageing drugs prevent radiotherapy impact
Wed May 25th - The long-term impact of radiation therapy for cancer could be limited with a class of drugs called senolytics, researchers say. More
RECENT COMMENTS
On 09/10/2020 William Haworth wrote:
How long is recovery time after proceedure... on Ablation cuts atrial fibrillat...
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote:
https://epidemicj17.imascientist.org.uk/2017/06/21... on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...
OUR CLIENTS
THIS WEEK'S STORIES
Pharmaceuticals

Pharmaceuticals

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65

11/07/2019 - Most new drugs have no proven benefit - claim
More than 50% of new drugs are approved with little evidence that they offer added benefits, researchers claim today. More

09/07/2019 - Immunotherapy hope for bowel cancer patients
Immunotherapy could benefit people who have stopped responding to a bowel cancer drug, according to a major new study. More

08/07/2019 - Combination therapy improves advanced bowel cancer survival rates
A combination of targeted therapies can improve survival in patients with advanced bowel cancer and should replace chemotherapy, new data has revealed. More

04/07/2019 - Cannabis clinical trial urgent - MPs
The UK needs an "immediate" clinical trial established of the benefits of medicinal cannabis for intractable childhood epilepsy, MPs have said. More

03/07/2019 - Flu threat from antibiotics
Changes in the gut bacteria caused by antibiotics may increase the risks from flu infection by weakening the immune response, scientists have warned. More

02/07/2019 - How cancer super-drugs fail
Super-drugs designed to target common gene faults in cancers may have wildly varying effects depending on the type of disease, British researchers report today. More

28/06/2019 - Myeloma heads cancer survival improvements
Survival rates for myeloma patients in England have improved dramatically this decade because of new treatments, a charity has revealed. More

13/06/2019 - Harm concerns linked to youth epilepsy treatment
Treatment guidelines for young people with epilepsy could be reviewed after a Swedish study found a group of drugs is linked to an increased risk of suicidal behaviour. More

11/06/2019 - Gene study closes in on pneumonia vaccine resistance
A major genetic research project has identified 621 strains of Streptococcus pneumoniae, it was announced last night. More

04/06/2019 - Immunotherapy hope for head and neck cancer
An immunotherapy has proved better than aggressive chemotherapy in the treatment of recurrent head and neck cancer, a conference will hear today. More

29/05/2019 - Progress on compound against superbugs
British scientists say they have found a new molecular compound that works against multidrug resistant bacteria such as E. coli. More

29/05/2019 - Gender response to chemotherapy investigated
Women given chemotherapy for oesophagogastric cancer had better survival than men – but experienced worse side effects, a UK-based research project has found. More

28/05/2019 - Gene study offers new Strep A vaccine hope
A major genetic analysis may have pin-pointed targets for vaccines against Group A streptococcus, it was announced last night. More

23/05/2019 - Warning on growing palliative care needs
The number of people needing palliative care globally is set to double in the next 40 years, according to a new projection. More

23/05/2019 - Red wine compound investigated for hypertension care
A compound produced by fruits in response to injury or attack could hold the key for to new treatments for hypertension, researchers report today. More

16/05/2019 - Liquid biopsy could help to halt metastatic cancer
A liquid biopsy could help to identify cancer patients who are at risk of their disease spreading, a conference heard yesterday (15 May 2019). More

16/05/2019 - World's first 'Darwinian' cancer drug programme announced
The world’s first ‘Darwinian’ drug discovery programme, designed to tackle cancer’s ability to evolve resistance to treatment, is to be launched in the UK, it is announced today. More

09/05/2019 - Welcome for MS drug u-turn
The first drug to slow the development of primary progressive multiple sclerosis is set to be supported for use in the NHS, it was announced today. More

08/05/2019 - TB elimination needs political input
Political "indifference" is hindering the success of tuberculosis elimination targets, an expert warned last night. More

07/05/2019 - Retinoblastoma gene points to prostate problems
A gene linked to eye cancer may also indicate a man's risk of developing aggressive forms of prostate cancer, British researchers reported last night. More

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65

Printer friendly page Printer friendly page

CATEGORIES